학술논문
The Addition of Gemtuzumab Ozogamicin to Intensive Chemotherapy in Older Patients with AML Produces a Significant Improvement in Overall Survival: Results of the UK NCRI AML16 Randomized Trial
Document Type
Abstract
Author
Source
In Blood 18 November 2011 118(21):582-582
Subject
Language
ISSN
0006-4971